Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3803635 | 0.98 | PKM (0.41) | PKML3MBTL1HPGDALDH1A1 | |
| SCHEMBL26778517 | 0.76 | CTSK (0.37) | — | |
| SCHEMBL17903547 | 0.75 | PKM (0.41) | PKML3MBTL1HPGDALDH1A1 | |
| SCHEMBL22623129 | 0.73 | PKM (0.42) | PKML3MBTL1HPGDALDH1A1 | |
| SCHEMBL26778508 | 0.71 | HDAC6 (0.36) | — | |
| SCHEMBL26778526 | 0.71 | — | — | |
| SCHEMBL22215301 | 0.69 | DNM1 (0.39) | — | |
| SCHEMBL23838524 | 0.69 | GPR88 (0.31) | — | |
| SCHEMBL13319540 | 0.69 | — | — | |
| SCHEMBL24623065 | 0.68 | CYP2C19 (0.40) | L3MBTL1HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100152128-A1 | Antiviral Agents | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) | 2010-06-17 | — | — | US | disclosed |
| US-20100152128-A1 | Antiviral Agents | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) | 2010-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152128-A1 | Antiviral Agents | EIF2AK2, MAVS, HAVCR2 | PKM 2259/4885L3MBTL1 3385/4885HPGD 2483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.